- The BRL 35 million Series A round also included Floating Point and FIR Capital;
- Nexodata claims to serve 1.5 million patients a year.
Brazil‘s physicians platform Nexodata, which developed a digital prescription platform, raised BRL 35 million in a round of funds that include Mercado Libre, Hospital Albert Einstein, and the family office of the founder of XP, Guilherme Benchimol.
The company, which connects physicians and pharmacies and operates in more than 3,000 cities in Brazil, says it operates through a network of 25,000 pharmacies and provides a digital prescription of medicines for more than 60,000 doctors, about 12% of the total number of these professionals in Brazil.
The Series A round also included Floating Point and FIR Capital. Previous investors that followed the new funding include LTS Investments, Arpex Capital, and IKJ Capital, the company said in a press release.
Nexodata claims to serve 1.5 million patients a year and was founded in 2017 by Pedro Dias and Lucas Lacerda, former co-founders of health tech Vitta, acquired last year by Stone.
The proceeds will be used to launch a marketplace, the company’s main project for 2021. “Through it, patients with a digital prescription will be able to buy their medicines in less than a minute without leaving home,” the company said in a statement.
The expectation is to exceed BRL 400 million in medicines transacted through Nexodata’s systems this year. In addition, it expects to increase from approximately 50% to 70% this year the number of healthcare companies listed on Brazil‘s stock exchange B3 that use its services.